Forward Pharma loses Tecfidera patent appeal against Biogen
Ruling secure Biogen’s Tecfidera exclusiity until 2028.
Read More
Author: George Underwood
Bayer, Orion drug shows strong results in prostate cancer
Drug significantly extended metastasis-free survival compared to placebo
Read More
Medidata teams with Pharm-Olam
CRO hopes partnership will accelerate drugs’ time to market
Read More
Revlimid shows significant PFS improvement in smoldering multiple myeloma
Company says drug could ‘play an important role in delaying the progression of smoldering myeloma into active myeloma’
Read More
Accelerated Access Collaborative announces first Rapid Uptake Products for NHS
Roche Diagnostics tests among seven selected for new scheme
Read More- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
